ID

34541

Description

A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics; ODM derived from: https://clinicaltrials.gov/show/NCT02470481

Link

https://clinicaltrials.gov/show/NCT02470481

Keywords

  1. 1/19/19 1/19/19 -
  2. 2/11/20 2/11/20 - Christian Arras
  3. 3/4/20 3/4/20 - Christian Arras
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 19, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Psoriatic Arthritis NCT02470481

Eligibility Psoriatic Arthritis NCT02470481

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient must be a man or woman aged 18 to 65 years of age, inclusive
Description

ID.1

Data type

boolean

the patient must have an established diagnosis of psoriasis (based upon clinical evidence, and documented medical history [19])
Description

ID.2

Data type

boolean

the patient must be able to read and write in the target language (english, mandarin or korean; or other relevant target languages)
Description

ID.3

Data type

boolean

each patient must sign an informed consent form (icf) indicating that he or she understands the purpose of and procedures required for the study and are willing to participate in the study
Description

ID.4

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
an established diagnosis of psoriatic arthritis
Description

ID.5

Data type

boolean

ever have received systemic treatment with a disease modifying antirheumatic drug (dmard) for arthritis or spondylitis (inflammatory back pain)
Description

ID.6

Data type

boolean

ever have received systemic treatment with a biologic therapy for psoriasis (including infliximab, golimumab, ustekinumab, adalimumab or etanercept)
Description

ID.7

Data type

boolean

a history of employment in or are currently employed in the healthcare industry; or
Description

ID.8

Data type

boolean

participated in the translation and linguistic validation of the earp questionnaire
Description

ID.9

Data type

boolean

Similar models

Eligibility Psoriatic Arthritis NCT02470481

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patient must be a man or woman aged 18 to 65 years of age, inclusive
boolean
ID.2
Item
the patient must have an established diagnosis of psoriasis (based upon clinical evidence, and documented medical history [19])
boolean
ID.3
Item
the patient must be able to read and write in the target language (english, mandarin or korean; or other relevant target languages)
boolean
ID.4
Item
each patient must sign an informed consent form (icf) indicating that he or she understands the purpose of and procedures required for the study and are willing to participate in the study
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
an established diagnosis of psoriatic arthritis
boolean
ID.6
Item
ever have received systemic treatment with a disease modifying antirheumatic drug (dmard) for arthritis or spondylitis (inflammatory back pain)
boolean
ID.7
Item
ever have received systemic treatment with a biologic therapy for psoriasis (including infliximab, golimumab, ustekinumab, adalimumab or etanercept)
boolean
ID.8
Item
a history of employment in or are currently employed in the healthcare industry; or
boolean
ID.9
Item
participated in the translation and linguistic validation of the earp questionnaire
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial